# Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain

> **NCT00484029** · PHASE2 · COMPLETED · sponsor: **Capnia, Inc.** · enrollment: 100 (actual)

## Conditions studied

- Temporomandibular Disorders
- Pain
- Headaches

## Interventions

- **DRUG:** Nasal Carbon Dioxide
- **OTHER:** Air

## Key facts

- **NCT ID:** NCT00484029
- **Lead sponsor:** Capnia, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-10
- **Final completion:** 2008-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2010-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00484029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00484029, "Nasal Carbon Dioxide (CO2)for the Treatment of Temporomandibular Disorders (TMD)Related Pain". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00484029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*